Non-invasive pre-implantation genetic testing’s reliability for aneuploidy using Cell-free DNA in embryo culture media

Handayani, Nining and Aubry, Daniel and Boediono, Arief and Bowolaksono, Anom and Sini, Ivan and Haq, Noer Muhammad Dliyaul and Sirait, Batara I. and Periastiningrum, Gusti and Mutia, Kresna and Wiweko, Budi (2024) Non-invasive pre-implantation genetic testing’s reliability for aneuploidy using Cell-free DNA in embryo culture media. Journal of Gynecology Obstetrics and Human Reproduction, 53 (8). pp. 1-6. ISSN 2468-7847

	Text Noninvasivepreimplantationgenetic.pdf Download (830kB)
	Text (Korespondensi) KorespondensiNoninvasivepreimplantationgenetic.pdf Download (1MB)
	Text (Hasil_Turnitin) HasilTurnitinNoninvasivepreimplantationgenetic.pdf Download (1MB)

Abstract

Objective: The presence of embryonic cell-free DNA (cfDNA) in spent embryo culture media (SECM) may offer valuable advantages for non-invasive testing of embryo ploidy or genetic characteristics compared to tro phectoderm (TE) biopsy. This study aimed to assess the diagnostic potential of SECM cfDNA as a non-invasive sample for chromosomal copy number testing in blastocysts within the clinical setting of in-vitro fertilization. Method: This prospective observational study collected 28 SECM cfDNA samples matched with TE biopsy samples from 21 infertile couples who underwent IVF-PGT-A cycles. SECM samples were obtained from blastocysts that were cultured for approximately 5/6 days in an uninterrupted time-lapse incubator. Both sets of samples were collected during the biopsy procedure. The Variseq Illumina platform was utilized for ploidy measurement. The study evaluated the informativity and interpretability of SECM cfDNA, concordance of general ploidy status, and sex chromosome agreement between the two sample types. Results: SECM cfDNA had a high informativity rate (100 %) after double amplification procedure, with a result interpretability of 93 %. Two out of the 28 SECM cfDNA samples were uninterpretable and regarded as overall noise samples. The diagnostic potential of SECM cfDNA, when compared to TE biopsy the standard reference, was relatively low at 50 %. Maternal DNA contamination remains the major obstacle that hinders the widespread clinical adoption of SECM cfDNA in the routine practice of pre-implantation genetic testing for aneuploidy within IVF settings. Conclusion: A significant modification must be implemented in the IVF laboratory to minimize DNA contami nation and this necessitates suggesting adjustments to oocyte denudation, embryo culture media preparation, and sample collection procedures. Keywords: Cell-free DNA non-invasive PGT-A PGT-A Ploidy analysis IVF

Actions (login required)

View Item